Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Trending Topics

    business

    Post stake buy, GSK may eye acquisition

    After the UK parent of GlaxoSmithKline Pharmaceutical announced an open offer to increase its stake from 50.3 percent to 75 percent at a cost of Rs 6,400 crore, CNBC-TV18 spoke with an industry veteran, Former Pfizer India MD Kewal Handa to get his views.

    first published: Dec 16, 2013 04:49 pm

    LATEST VIDEOS

    Watch More →

    A collection of the most-viewed Moneycontrol videos.

    Watch and Follow our leading shows

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347